For IPO Boutique's "scale of 1 to 5" BUY rating on Aurion Biotech, Inc., and our comprehensive analysis, click "Buy Market Research".
About Aurion Biotech, Inc. (adapted from Aurion Biotech, Inc. prospectus): They are a clinical-stage biotechnology company committed to developing and commercializing disease-modifying, regenerative therapies to restore vision to millions of patients worldwide.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "AURN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
